Ttp hercules trial
WebNov 29, 2024 · Caplacizumab has been studied two randomized controlled trials (TITAN [33,34], EudraCT 2010-019375-30 and HERCULES [35], EudraCT 2015-001098-42) in patients with acute autoimmune TTP, and has been ...
Ttp hercules trial
Did you know?
WebMay 25, 2024 · Approval was based on results from the phase 3 HERCULES trial (n = 145). When caplacizumab was added to plasma exchange and immunosuppression, a … WebScully et al (2024; HERCULES trial; NCT02553317) stated in acquired thrombotic thrombocytopenic purpura (TTP), an immune-mediated deficiency of the von Willebrand factor-cleaving protease ADAMTS13 allows unrestrained adhesion of von Willebrand factor multimers to platelets and microthrombosis, which result in thrombocytopenia, hemolytic …
http://mdedge.ma1.medscape.com/hematology-oncology/article/185203/anemia/caplacizumab-improves-outcomes-attp WebAug 9, 2010 · Background: The efficacy and safety of caplacizumab (CPLZ) for patients with acquired thrombotic thrombocytopenic purpura (aTTP; also known as immune-mediated TTP) was demonstrated in the Phase 3 HERCULES trial, with a 28-day follow-up period after end of treatment.
WebNational Center for Biotechnology Information WebDec 19, 2024 · ATLANTA – Adding caplacizumab to standard therapy for acquired thrombotic thrombocytopenic purpura (aTTP) significantly improved platelet response and prevented recurrent episodes in an international, randomized, double-blind, phase 3 placebo-controlled trial. “Patients were 55% more likely to achieve normalization of platelet count …
WebJul 7, 2024 · Overall, our experience confirms the positive results of the TITAN and HERCULES trials. 3,4 Caplacizumab was effective in the treatment of aTTP and led to a …
WebDec 14, 2024 · HERCULES Trial. The trial enrolled 145 patients suffering acute episodes of aTTP. All patients received standard of care, including plasma exchange and steroids until resolution of the episode, and could have received monoclonal antibody therapy (rituximab [Rituxan]) or further immunosuppressive therapy per investigator practice. fly vpn for windowsWebApr 21, 2024 · The efficacy and safety of caplacizumab in individuals with acquired thrombotic thrombocytopenic purpura (aTTP) have been established in the phase 2 … green red color blindnessWebThe efficacy and safety of Cablivi were established in a pivotal clinical study and this was the HERCULES study. This was a phase III double-blind randomised control trial of 145 adult patients that had acquired TTP. flyvpn chinaWebAug 5, 2024 · Caplacizumab was evaluated in the phase 3 HERCULES trial (NCT02553317) and led to fewer days in hospital and intensive care unit (ICU) compared with placebo [5]. Furthermore, refractory aTTP was reduced to 0 and recurrence was … flyvpn premium account 2021WebSep 17, 2015 · Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura (HERCULES) The safety and scientific validity of this study is … fly vpn pcWebdata:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAKAAAAB4CAYAAAB1ovlvAAAAAXNSR0IArs4c6QAAAw5JREFUeF7t181pWwEUhNFnF+MK1IjXrsJtWVu7HbsNa6VAICGb/EwYPCCOtrrci8774KG76 ... fly vpn pc downloadWebIntroduction: Acquired thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease characterized by thrombotic microangiopathy leading to end-organ damage. The standard of care ... Given the efficacy of caplacizumab in the TITAN and HERCULES trials, we conducted a cost effectiveness analysis (CEA) ... green red fetch land